COMMUNIQUÉS West-GlobeNewswire

FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
18/08/2026
Discussion Paper Supports FDA’s Innovation and Global Leadership Strategic Pillar; Public Docket Opens on Regulations.gov Silver Spring, Md., Aug. 18, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today [...]
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
18/08/2026
Acquisition expands Cellution Biologics’ human tissue-based portfolio and marks its entry into the U.S. reconstructive surgery market ROSWELL, Ga., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc. (“Cellution [...]
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
18/08/2026
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026 Halle (Saale) / Munich, Germany, August 18, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon [...]
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
18/08/2026
Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization [...]
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
18/08/2026
Total revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company’s guidance of $46-48 million IM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company’s guidance of $44-46 million, marking the [...]
BrewDog Unwraps Its 2026 Advent Calendar
18/08/2026
New brews, bold flavours and one unmissable 24-day countdown to Christmas ELLON, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Scottish craft brewer BrewDog , by Tilray Brands, Inc. , today unveiled its 2026 Advent [...]
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
18/08/2026
Primary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product cost per percent total body surface area treated (p<0.001) 96% reduction in preparation time and comparable clinical [...]
PROMIXX Pursuit Insulated Shaker Bottle Keeps Protein Shakes Ice Cold for 12+ Hours, Outlasting Standard Gym Bottles
18/08/2026
Dual wall vacuum insulated design is built for full gym sessions, commutes and all day use, without the drink going warm CARDIFF, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- As gym sessions run longer through the [...]
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
18/08/2026
Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development experience including roles at Sumitomo Pharma, Takeda, and Novartis Appointment further strengthens Entera’s clinical [...]
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
18/08/2026
BRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule [...]
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
18/08/2026
Deal valued at $11 million in cash, with $8 million at closing and up to $3 million in additional milestone payments over the next 18 months Divestiture further concentrates Elutia’s attention and resources on the [...]
Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients
18/08/2026
First patients dosed in OVERTURE, a Phase 1b/2a study evaluating EYC-0305, a potential long-acting anti-VEGF therapy designed for six-month or longer dosing intervals via standard intravitreal injection Milestone marks [...]
MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
18/08/2026
The MediBeacon ® TGFR™ System is a first-in-kind product for point-of-care kidney function assessment Winners will be announced at the 20th annual Prix Galien USA Awards Ceremony on October 29, 2026, at the American [...]
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”
18/08/2026
– Jeromy Brink, MD, Mayo Clinic–trained vascular surgeon in Phoenix, is the first surgeon in Arizona to implant Symvess, the first and only FDA-approved bioengineered human blood vessel – – Symvess is available off-the- [...]
Noom Appoints Jim Bugden Chief Financial Officer as Company Enters Next Phase of Growth
18/08/2026
Financial and operational leader with deep experience scaling high-growth technology companies joins Noom to support the company's continued expansion PRINCETON, N.J., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Noom , the [...]
CRNA Coach Amanda Kay Launches $5 Live Bootcamp as The Mindful CRNA Expands Support for Nurses Entering Anesthesia
18/08/2026
CHICAGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Amanda Kay, MSN, CRNA opens a live three-day CRNA Bootcamp in late August, adds two coaching portals for nurses already in school, and confirms a pilot program beginning [...]
SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million
18/08/2026
SciSparc Invests C$2.7 million and holds approximately 44.6% of NeuroThera’s issued and outstanding common shares following the financing TEL AVIV, Israel, Aug. 18, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC [...]
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
18/08/2026
Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“ Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology [...]
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
18/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for PLN- [...]

Pages